Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy.

导出 OA

翻译打印收藏纠错

作者： Luis E,Echeverría ^[1] ; Lyda Z,Rojas ^[2] ; Sergio Alejandro,Gómez-Ochoa ^[3] ; Oscar L,Rueda-Ochoa ^[2] ; Cristian David,Sosa-Vesga ^[4] ; Taulant,Muka ^[5] ; James L,Januzzi ^[6] ; Rachel,Marcus ^[7] ; Carlos A,Morillo ^[8]

作者单位： Heart Failure and Cardiac Transplant Division, Fundación Cardiovascular de Colombia, Floridablanca, Colombia. ^[1] Public Health and Epidemiological Studies Group, Cardiovascular Foundation of Colombia, Floridablanca, Colombia. ^[2] Research Group and Development of Nursing Knowledge (GIDCEN-FCV), Research Center, Cardiovascular Foundation of Colombia, Floridablanca, Santander, Colombia. ^[3] Electrocardiography Research Group, Medicine School, Universidad Industrial de Santander, Bucaramanga, Colombia. ^[4] Universidad Industrial de Santander, Bucaramanga, Santander, Colombia. ^[5] Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland. ^[6] Massachusetts General Hospital, Harvard Clinical Research Institute, Boston, MA, United States of America. ^[7] Department of Cardiology, Washington Hospital Center, Washington, District of Columbia, United States of America. ^[8] Department of Cardiac Sciences, Cumming School of Medicine, Libin Cardiovascular Institute of Alberta, University of Calgary, Alberta, Canada. ^[9] Department of Medicine, Cardiology Division, McMaster University, PHRI-HHSC, Hamilton, Ontario, Canada. ^[10]